GeneNews completes deal to bring ColonSentry to China

GeneNews (TSX:GEN) has executed a formal marketing partnership agreement with GeneDiagnostics, a private clinical research and services company in China, to market ColonSentry, the world’s first blood-based test to determine a person’s current risk for colorectal cancer. Under the accord, GeneDiagnostics has obtained non-exclusive rights to market and sell the ColonSentry test in Shanghai and [...]

GeneNews partners to sell ColonSentry in China

GeneNews (TSX:GEN) signed a binding term sheet with GeneDiagnostics, a private clinical research and services company in China, for the non-exclusive rights to market ColonSentry, the world’s first blood-based test to determine a person’s current risk for colorectal cancer. GeneNews expects negotiations will lead to a formal marketing partnership agreement by the end of June. [...]